Carcinoma in situRASSF1A average methylation was 17% ± 12.5% versus invasive breast cancer 27.4% ± 17%, confirming previous reports that RASSF1A methylation may be associated with the degree of cancer invasion and be an early event in breast cancer. This evidence concerns the gene RASSF1 and carcinoma.